期刊文献+

猪繁殖与呼吸综合征病毒ORF5基因疫苗肌肉注射诱导小鼠的细胞免疫 被引量:4

Cellular Immune Responses of BALB/c Mice Immunized with pcDNA-PRRSV-ORF5 DNA Vaccine of Different Doses After Intramuscular Injection
在线阅读 下载PDF
导出
摘要 将猪繁殖与呼吸综合征病毒(PRRSV)ORF 5基因疫苗(pcDNA-PRRSV-ORF 5)以50、100、200μg 3个剂量肌注免疫BALB/c小鼠,以PBS和空载体质粒pcDNA为对照,采用流式细胞仪(FACS)、淋巴细胞增殖试验(M TT法)分别对小鼠外周血中CD4+、CD8+T淋巴细胞数和淋巴细胞转化功能进行了检测。结果,3个剂量的pcDNA-PRRSV-ORF 5接种小鼠后,其外周血都对ConA有明显的反应性,试验组与对照组比较差异极显著(P<0.01)或显著(P<0.05),CD4+T淋巴细胞数在免疫后7 d高于对照组(P<0.01),CD8+T淋巴细胞在免疫后28 d高于对照组,大剂量基因疫苗免疫小鼠的细胞免疫应答高于中、小剂量。结果表明,pcDNA-PRRSV-ORF 5免疫小鼠能够诱导机体产生良好的细胞免疫应答,并表现一定的剂量依赖性。 BALB/c mice were immunized with 50,100,200μg of pcDNA-PRRSV-ORF5 DNA vaccine respectively by the route of intramuscular injection, with PBS and pcDNA3.1 (+) as controls. Fluorescence activated cell sorter(FACS)was used to detect the number of CO4^+ .CO8^+, T lymphocyte proliferation test (MTT) was used to detect the proliferative of T-lymphocyte cell in peripheral blood lymphocytes of mice vaccinated with pcDNA-PRRSV-ORF5 DNA vaccine. The results showed ConA response of T-lymphocytes in blood was highly significant differences between all experiment groups and the control(P〈0. 01). The number of CD4^+ T-lymphocytes of experiment groups was significantly higher than that of the control 7 days after vaccination. The number of CD8^+ T-lymphocytes of experiment groups was higher than that of the control group 28 days after vaccination. Mice immunized with higher dose (200μg) of DNA vaccine revealed the higher cellular immune response than mice immunized with lower dose (100, 50μg) of DNA vaccine. The results demonstrated that pcDNA-PRRSV-ORF5 DNA vaccine could induce a good cellular immune response and some dose-dependent relationship.
出处 《中国兽医学报》 CAS CSCD 北大核心 2006年第2期111-114,共4页 Chinese Journal of Veterinary Science
基金 四川省生物技术项目(01NG018-03) 国家科技攻关重大项目(2004BA901A03) 四川省重点建设学科项目(SZD0418)
关键词 猪繁殖与呼综合征病毒ORF5基因疫苗 细胞免疫 小鼠 porcine reproductive and respiratory syndrome virus ORF5 DNA vaccine cellular immune response mice
  • 相关文献

参考文献12

  • 1Yankauckas M A,Morrow J E,Parker S E,et al.Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene[J].DNA Cell Biol,1993,(12):771-776.
  • 2刘民,马华,李柏青.MTT法检测小鼠淋巴细胞增殖性反应探讨[J].中国实验动物学杂志,1999,9(3):146-149. 被引量:63
  • 3Krieg A M,Yi A K,Schorr J,et al.The role CpG dinucleotides in DNA vaccines[J].Trends Microbiol,1998,(6):23-27.
  • 4Feng W H,Tompkins M B,Xu J S,et al.Analysis of constitutive cytokine expression by pigs infected in-utero with porcine reproductive and respiratory syndrome virus[J].Vet Immunol Immunopathol,2003,94:35-45.
  • 5Cohen J.Naked DNA points way to vaccines[J].Science,1993,259(5102):1 691-1 692.
  • 6Doolan D L,Sedegah M,Hedstrom R C,et al.Circumventing genetic restriction of protection against malaria with multigene DNA immunization:CD8+ T cell-,interferon λ and nitric oxidedependent immunity[J].J Exp Med,1996,183:1 739-1 746.
  • 7Manickan E,Rouse R J,Yu Z,et al.Genetic immunization against herpes simplex virus.Protection is mediated by CD4+ T lymphocytes[J].J Immunol,1995(155):259-265.
  • 8Zelphati C,Nguyen C,Ferrari M,et al.Stable and monodisperse lipoplex formulations for gene delivery[J].Gene Ther,1998,5(9):1 272-1 282.
  • 9熊一力,刘惠萍,祖萍,贾彦征,张宜俊.大剂量HBsAg疫苗对小鼠细胞免疫应答的调节作用[J].中国病理生理杂志,2003,19(9):1250-1252. 被引量:2
  • 10Davis H L,Millan C L,Watkins S C,et al.Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen -expressing plasmid DNA[J].Hum Gene Ther,1995,(6):1 447-1 456.

二级参考文献26

  • 1Pol S, Nalpas B, Driss F, et al. Multicenter study group. Efficacy and limitations of a specific immunotherapy in chronic hepatitis B[J]. J Hepatol,2001,34(6) :917 - 921.
  • 2Senturk H, Tabazk F, Akdogan M, et al. Therapeutic vaccination in chronic hepatitis B[J]. J Gastroenterol Hepatol,2002,17(1) :72- 76.
  • 3Shen G, Zhou L. Modem immunology experimental technology[M]. Second ed. Wuhan: Wuhan Sci Technol Pupl,2002,435- 437.
  • 4Sette AD,Oseroff C,Sidney J,et al.Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice[J].J Immunol,2001,166(2):1389-1397
  • 5Tangri S, Ishioka GY, Huang X, et al. Structural features of peptide of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild- type peptide[J]. J Exp Med, 2001, 194(6):833-846.
  • 6Kakimi K, Lane TE, Chisari FV,et al. Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver[J].J Immunol, 2001, 167(12) :6701 - 6705.
  • 7Heintges T, Petry W, Kaldewey M, et al. Combination therapy of active HBsAg vaccination and interferon- alpha in interferon-alpha nonresponders with chronic hepatitis B[J]. Dig Dis Sci, 2001,46(4) :901 - 906.
  • 8Livingston BD, Newman M, Crimi C, et al. Optimization of epitope proessing enhances immunogenieity of multiepitope DNA vaccines[J]. Vaccine, 2001, 19(32) :4652 - 4660.
  • 9Akbar SM, Abe M, Masumoto T, et al. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic ceils[ J ].J Hepatol, 1999,30(5) :755 - 764.
  • 10Dahmen A, Heraog- Hauff S, Bocher WO, et al. Clinical and immunological efficacy of intradennal vaccine plus lamivudine with or without interleukin- 2 in patients with chronic hepatitis B[J]. J Med Virol, 2002, 66(4) :452 - 460.

共引文献71

同被引文献49

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部